Recently, the overexpression of PDE5 has been reported in several human carcinomas, including breast cancer, and suggested that PDE5 expression has positive correlation with tumor grade, lymph node involvement, and invasive potential, as well as decreasing survival rate in patients. This evidence concerns the gene PDE5A and breast carcinoma.